Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
VRTX: Vertex Pharmaceuticals Incorporated Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
VRTX
The Story
VRTX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+9.6% / yr
Operating margin
39.0%
ROIC
17.7%
Financially safe
Strong
Debt / equity
0.10×
Interest coverage
463.7×
Current ratio
3.02×
Valuation
Unrated
P/E ratio
28.0×
Vertex Pharmaceuticals Incorporated
VRTX
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Vertex Pharmaceuticals Incorporated
VRTX
NASDAQ
·
USD
·
Closed
$477.10
−0.95%
$477.10
−$4.60 (0.95%)
52W Range
67th
pctl
Volume
0.61×
avg
Mkt Cap
121.09B
USD
P/E
28.0
TTM
Div Yield
–
ann
52W Range
67th
pctl
Volume
0.61×
avg
Market Cap
121.09B
USD
P/E Ratio
28.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings